ESC Premium Access

Drug effect of luseogliflozin and voglibose on heart failure with preserved ejection fraction in diabetic patients: a multicenter randomized-controlled trial

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Hajime Kihara

Kihara Cardiovascular Clinic, Asahikawa (Japan)
0 follower

8 more presentations in this session

Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial

Speaker: Doctor D. Fouassier (Paris, FR)


Inhaled iloprost, exercise hemodynamics, and ventricular performance in heart failure with preserved ejection fraction

Speaker: Doctor J. Cheng (Taipei, TW)


Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis

Speaker: Associate Professor A. Kalogeropoulos (Stony Brook, US)


Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction

Speaker: Mr M. Godet (Rouen, FR)


Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study

Speaker: Doctor D. Pascual Figal (Murcia, ES)


Access the full session

New treatment studies in heart failure

Speakers: Doctor H. Kihara, Doctor D. Fouassier, Doctor J. Cheng, Associate Professor A. Kalogeropoulos, Mr M. Godet...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by